CD99 Drives Terminal Differentiation of Osteosarcoma Cells by Acting as a Spatial Regulator of ERK 1/2†

Differentiation therapy is an attractive treatment for osteosarcoma (OS). CD99 is a cell surface molecule expressed in mesenchymal stem cells and osteoblasts that is maintained during osteoblast differentiation while lost in OS. Herein, we show that whenever OS cells regain CD99, they become prone t...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Bone Miner Res
Main Authors: Sciandra, Marika, Marino, Maria Teresa, Manara, Maria Cristina, Guerzoni, Clara, Grano, Maria, Oranger, Angela, Lucarelli, Enrico, Lollini, Pier-Luigi, Dozza, Barbara, Pratelli, Loredana, Di Renzo, Maria Flavia, Colombo, Mario Paolo, Picci, Piero, Scotlandi, Katia
Formato: Artigo
Idioma:Inglês
Publicado: Blackwell Publishing Ltd 2014
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4255300/
https://ncbi.nlm.nih.gov/pubmed/24677094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jbmr.2141
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares